Vortioxetine as a potential alternative for patients with escitalopram‐induced jitteriness/anxiety syndrome: A report of three cases

Kaoru Arai, Mari Nonaka, Shoko Shimada, Masayuki Nakamura · 2023

Read Vortioxetine as a potential alternative for patients with escitalopram‐induced jitteriness/anxiety syndrome: A report of three cases by Kaoru Arai, Mari Nonaka, Shoko Shimada, Masayuki Nakamura (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11114283.txt.

Description

Kaoru Arai, Mari Nonaka, Shoko Shimada, and Masayuki Nakamura present a 2023 report of three patients whose antidepressant sparked a jittery anxiety state. The syndrome, a known early side effect of such drugs, leaves patients restless and wound up. All three cases arose on escitalopram, a widely used drug for depression. The authors test a switch to a second drug, vortioxetine, as a way out.

One man's mood shot up three months in, with racing talk and acts that broke his routine. The switch settled him. A woman's mood spiked in six days; after the first drug stopped and three others failed, she sank and had thoughts of self-harm. The second drug steadied her and she went back to work. A third case rounds out the set. Small case sets can still flag a workable switch.

Catalog record

CREATORKaoru Arai, Mari Nonaka, Shoko Shimada, Masayuki Nakamura
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE17 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11114283

Browse the full library · About the Tower of Babel